ArticleJournal of computer-aided molecular design2021
Binding affinity prediction for binary drug-target interactions using semi-supervised transfer learning.
Article in Journal of computer-aided molecular design, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Machine Learning Approaches for Compound-Target Interaction Prediction: A Review.Foods (Basel, Switzerland) · 2026Review
- Improving drug-target affinity prediction by adaptive self-supervised learning.PeerJ. Computer science · 2025Article
- The Art of Finding the Right Drug Target: Emerging Methods and Strategies.Pharmacological reviews · 2024Review
- CCL-DTI: contributing the contrastive loss in drug-target interaction prediction.BMC bioinformatics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the field of drug-target interactions prediction, the majority of approaches formulated the problem as a simple binary classification task. These methods used binary drug-target interaction datasets to train their models. The prediction of drug-target interactions is inherently a regression problem and these interactions would be identified according to the binding affinity between drugs and targets. This paper deals the binary drug-target interactions and tries to identify the binary interactions based on the binding strength of a drug and its target. To this end, we propose a semi-supervised transfer learning approach to predict the binding affinity in a continuous spectrum for binary interactions. Due to the lack of training data with continuous binding affinity in the target domain, the proposed method makes use of the information available in other domains (i.e. source domain), via the transfer learning approach. The general framework of our algorithm is based on an objective function, which considers the performance in both source and target domains as well as the unlabeled data in the target domain via a regularization term. To optimize this objective function, we make use of a gradient boosting machine which constructs the final model. To assess the performance of the proposed method, we have used some benchmark datasets with binary interactions for four classes of human proteins. Our algorithm identifies interactions in a more realistic situation. According to the experimental results, our regression model performs better than the state-of-the-art methods in some procedures.
Indexed as
Identifiers
34189637What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.